TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Takeda Pharma A/S
Closing information (x1000 NOK)
Closing information | 2022/03 | 2021/03 | 2020/03 |
Turnover | 1,176,937 | 2,609,578 | 2,427,863 |
Earnings before taxes | 55,249 | 1,229,573 | 5,121,945 |
Total assets | 804,783 | 2,714,256 | 5,881,623 |
Current assets | 719,788 | 2,625,531 | 5,687,824 |
Current liabilities | 679,731 | 1,281,737 | 1,642,509 |
Equity capital | 105,061 | 1,408,117 | 4,187,595 |
- share capital | 13,062 | 13,591 | 15,623 |
Employees (average) | 350 | 350 | 350 |
Financial ratios
Fiscal year | 2022/03 | 2021/03 | 2020/03 |
Solvency | 13.1% | 51.9% | 71.2% |
Turnover per employee | 3,363 | 7,456 | 6,937 |
Profit as a percentage of turnover | 4.7% | 47.1% | 211.0% |
Return on assets (ROA) | |||
Current ratio | 105.9% | 204.8% | 346.3% |
Return on equity (ROE) | 52.6% | 87.3% | 122.3% |
Change turnover | -1,330,983 | 497,413 | -2,597 |
Change turnover % | -53% | 24% | 0% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/03 | 2021/03 | 2020/03 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.